v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 27, 2026
Dec. 28, 2025
Current assets    
Cash and cash equivalents $ 1,039 $ 1,062
Trade receivables, less allowances for credit losses ($15 and $26 as of September 27, 2026 and December 28, 2025, respectively) 2,504 2,382
Inventories 1,815 1,666
Prepaid expenses and other receivables 410 432
Other current assets 171 155
Total current assets 5,939 5,697
Property, plant, and equipment, net 2,233 2,212
Intangible assets, net 8,330 8,694
Goodwill 9,251 9,509
Deferred taxes on income 244 237
Other assets 674 727
Total Assets 26,671 27,076
Current liabilities    
Loans and notes payable 1,121 1,453
Accounts payable 2,685 2,473
Accrued liabilities 1,522 1,159
Accrued rebates, returns, and promotions 770 755
Accrued taxes on income 118 105
Total current liabilities 6,216 5,945
Total long-term debt 7,085 7,071
Deferred taxes on income 2,297 2,354
Employee-related obligations 341 340
Other liabilities 570 601
Total liabilities 16,509 16,311
Commitments and contingencies (Note 13)
Stockholders’ Equity    
Preferred stock, $0.01 par value, 750,000 shares authorized; no shares issued and outstanding as of September 27, 2026 and December 28, 2025 0 0
Common stock, $0.01 par value, 12,500,000 shares authorized; 1,941,266 and 1,920,880 shares issued and outstanding as of September 27, 2026, respectively; 1,936,502 and 1,916,115 shares issued and outstanding as of December 28, 2025, respectively 19 19
Additional paid-in capital 16,437 16,348
Treasury stock, 20,387 and 20,387 shares at cost as of September 27, 2026 and December 28, 2025, respectively (439) (439)
Accumulated deficit (447) (204)
Accumulated other comprehensive loss (5,408) (4,959)
Total stockholders’ equity 10,162 10,765
Total Liabilities and Stockholders’ Equity $ 26,671 $ 27,076